Evaluating diagnostic methods for Primary Sjögren's Syndrome
Official title: Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort
Run by University Hospital, Brest · NCT03681964 · Data updated 2026-11-12
This study is testing different ways to diagnose Primary Sjögren's Syndrome to see which methods work best for patients who might have it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | September 28, 2015 |
| Main results expected | September 28, 2020 |
| Study ends | September 28, 2030 |
| Registry record updated | September 24, 2018 |
| Trial ID | NCT03681964 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who are suspected of having Primary Sjögren's Syndrome and are willing to undergo a standardized evaluation.
✕Probably not a fit
Patients who oppose participation in the study will not benefit from its findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on assessing the diagnostic performance of various criteria used for classifying, diagnosing, and predicting outcomes in patients with Primary Sjögren's Syndrome (pSS). Patients suspected of having pSS will undergo a standardized evaluation to gather data on the effectiveness of these diagnostic methods. The study aims to improve the accuracy of pSS diagnosis and enhance patient management strategies.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses of Primary Sjögren's Syndrome, improving patient outcomes and treatment approaches.
How similar studies have gone: While this study focuses on diagnostic evaluation, similar studies have shown promise in improving diagnostic accuracy for autoimmune conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with suspected pSS underwent a standardised evaluation Exclusion Criteria: * Opposition of patient
Where it's running
-
CHRU de Brest
Brest, France Recruiting
Study contacts
- Study coordinator: Valerie Devauchelle, MD,PhD
- Email: valerie.devauchelle-pensec@chu-brest.fr
- Phone: 33 (0) 2 98 34 72 64
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Unified care and integrated treatments for ADHD with substance use in prison settings
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
-
4D dynamic LAFOV FDG-PET to tell leftover cancer from post-radiation inflammation in head and neck squamous cell carcinoma
This study will test whether a 4D dynamic long‑axial‑field‑of‑view FDG‑PET scan can tell remaining head and neck squamous cell cancer from normal post‑radiation inflammation in adults about three months after finishing curative radiotherapy.
-
Imaging the anatomy of the eye socket (orbit)
This project looks at existing orbital imaging from adults to see how the eye muscles, optic nerve, and orbital fat are arranged.
-
Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism
This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.
-
Deneo Kid: an app to coordinate rehabilitation care for children and young people with neuromotor disabilities
This project will test whether the Deneo Kid app helps children and young people (age 2–25), their families, and rehabilitation teams share information and coordinate care more easily over three months.
-
Joint tissue analysis to understand rare and immunotherapy-related inflammatory arthritis
This project tests whether analyzing joint biopsy tissue can reveal distinct immune features in adults with inflammatory arthritis linked to rare autoimmune diseases or caused by cancer immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.